Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

61.31
+0.73001.21%
Post-market: 61.310.00000.00%19:30 EDT
Volume:2.33M
Turnover:142.36M
Market Cap:35.37B
PE:32.89
High:61.60
Open:60.53
Low:60.37
Close:60.58
52wk High:62.13
52wk Low:34.08
Shares:576.94M
Float Shares:392.53M
Volume Ratio:0.94
T/O Rate:0.59%
Dividend:0.91
Dividend Rate:1.48%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:5.18
PE(LYR):34.42

Loading ...

Royalty Pharma: Outlook 2026 Portfolio Receipts $3,400 Mln to $3,500 Mln, Interest Paid $350 Mln to $360 Mln

THOMSON REUTERS
·
Aug 05

Royalty Pharma Names Greg Raskin SVP, Head of Academic Initiatives

Reuters
·
Aug 03

Royalty Pharma Appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives

THOMSON REUTERS
·
Aug 03

Earning Preview: Royalty Pharma plc revenue is expected to increase by 1.34%, and institutional views are bullish

Earnings Agent
·
Jul 29

Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug

MT Newswires Live
·
Jul 22

Royalty Pharma Buys Cliramitug Royalty Stake from Neurimmune for up to $425 Million

Reuters
·
Jul 22

Neurimmune: in Q1 of 2027, Royalty Pharma Will Provide Another $125 Mln in Cash to Co

THOMSON REUTERS
·
Jul 22

Neurimmune Sells a Portion of Its Royalty Interest in Cliramitug to Royalty Pharma

THOMSON REUTERS
·
Jul 22

Neurimmune: Sold Portion of Its Royalty Interest in Cliramitug to Royalty Pharma for up to $425 Mln

THOMSON REUTERS
·
Jul 22

Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14

MT Newswires Live
·
Jul 18

Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend

Dow Jones
·
Jul 18

Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Royalty Pharma to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 16

Royalty Pharma to Announce Second Quarter 2026 Financial Results on August 5, 2026

THOMSON REUTERS
·
Jul 16

Royalty Pharma : TD Cowen Raises Target Price to $65 from $50

THOMSON REUTERS
·
Jul 13

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Royalty Pharma EVP Christopher Hite Sells USD 7.38 Million in Common Shares

Reuters
·
Jul 03

Royalty Pharma Forecasts Q2 Portfolio Receipts at $740 Million-$760 Million

Reuters
·
Jul 01

Royalty Pharma EVP, Chairman Partnering Christopher Hite Sells USD 8.15 Million in Common Shares

Reuters
·
Jun 26

Don't Ignore The Insider Selling In Royalty Pharma

Simply Wall St.
·
Jun 18